The role of dietary modification and nondrug therapy in dogs and cats with congestive heart failure

Veterinary Medicine

Volumn 93, Issue 10, 1998, Pages 919-926

  Goodwin, John Karl ^a   Strickland, Keith N ^b  

^a Veterinary Heart Institute   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009341032     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Goodwin, J.K.; Hamlin, R.L.: Preferences of veterinarians for drugs used to treat heart disease in dogs and cats - a 20 year follow-up study (abst.). J. Vet, Intern. Med. 7:118; 1993.
2. Dargie, H.J. et al: Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic congestive heart failure. Circulation 75(suppl. 4):98; 1987.
3. Freeman, L.M.: The role of cytokines in cardiac cachexia. Proc. ACVIM, ACVIM, Lakewood, Colo., 1996; pp 240-242.
4. Poehlman, E.T. et al: Increased resting metabolic rate in patients with congestive heart failure. Ann. Intern. Med. 121(11):860-862; 1994.
5. Zhao, S.P.; Zeng, L.H.: Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Intl. J. Cardiol. 58(3):257-261; 1997.
6. Roubenoff, R. et al: Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 40(3):534-539; 1997.
7. Freeman, L.M.; Roubenoff, R.: The nutrition implications of cardiac cachexia. Nutr. Rev. 52(10):340-347; 1994.
8. Freeman, L.M. et al: Elevated concentrations of tumor necrosis factor in dogs with congestive heart failure (abst.). J. Vet. Intern. Med. 8:146; 1994.
9. Meurs, K.M. et al: Serum necrosis factor concentration in cats with congestive heart failure (abst.). J. Vet. Intern. Med. 9:200; 1995.
10. Mizelle, H.L. et al: Abnormal cardiovascular responses to exercise during development of obesity in dogs. Am. J. Hypertension 7:374; 1994.
11. Pensinger, R.R.: Dietary control of sodium intake in spontaneous congestive heart failure in dogs. VM/SAC 59:752; 1964.
12. Roudebush, P.; Allen, T.A.: Effect of dietary sodium restriction and furosemide on hematologic, biochemical, and endocrine parameters in normal geriatric dogs (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1996; p 753.
13. International Small Animal Cardiac Health Council: Recommendations for the diagnosis of heart disease and the treatment of heart failure in small animals (mongr.). Academy of Veterinary Cardiology, Gainesville, Fla., 1992; pp 1-32.
14. Roudebush, P. et al: Dietary modification in cardiovascular disease. Small Animal Clinical Nutrition, 4th Ed. (M.S. Hand et al, eds.). Mark Morris Associates (in press).
15. Morris, M.L. et al: Low sodium diet in heart disease: How low is low? VM/SAC 71:225; 1976.
16. Roudebush, P. et al: The effect of combined therapy with captopril, furosemide and a sodium restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure. J. Vet. Intern. Med. 8:337-342; 1994.
17. Hamlin, R.L. et al: Effects of a controlled electrolyte diet, low in sodium, in healthy dogs. VM/SAC 59:743-746; 1964.
18. Tobian, L.: Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in people and animals. Am. J. Clin. Nutr. 65(suppl, 2):606S-611S; 1997.
19. Keene, B.W. et al: Myocardial L-Carnitine deficiency in a family of dogs with dilated cardiomyopathy. JAVMA 198:647; 1991.
20. Keene, B.W.: L-Carnitine deficiency in canine idiopathic dilated cardiomyopathy. Kirk's Current Veterinary Therapy XI Small Animal Practice. (R.W. Kirk; J.D. Bonagura, eds.). W.B. Saunders, Philadelphia, Pa., 1992; pp 780-783.
21. Pion, P.D. et al: Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 237:764; 1987.
22. Pion, P.D. et al: Effect of meal-feeding and food deprivation on plasma and whole blood taurine concentrations in cats (expanded abst.). J. Nutr. 121:S177; 1991.
23. Gavaghan, B.J.; Kittleson, M.D.: Dilated cardiomyopathy in an American cocker spaniel with taurine deficiency. Aust. Vet. J. 75:862-868; 1997.
24. Kittleson, M.D. et al: Results of the multicenter spaniel trial (MUST): Taurine and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration. J. Vet. Intern. Med. 11:204-211; 1997.
25. Kramer, G.A. et al: Plasma taurine concentrations in normal dogs and in dogs with heart disease. J. Vet. Intern. Med. 9:253-258; 1995.
26. Wigmore, S.J. et al: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12(suppl. 1):S27-S30; 1996.
27. Tisdale, M.J.; Dhesi, J.K.: Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model. Cancer Res. 50(16);5022-5026; 1990.
28. Freeman, L.M.: The use of fish oil in dogs with congestive heart failure (abst.). Proc. ACVIM, ACVIM, Lakewood, Colo., 1995; p 1018.
29. 10 to the myocardium and its protective effects on ischemic myocardium in beagles. Biomed. Clin. Aspects Coenzyme Q 5:99; 1986.
30. 10 with emphasis on cardiac patients. Biomed. Clin. Aspects Coenzyme Q 5:375; 1986.
31. 10 therapy for idiopathic dilated cardiomyopathy. Am. J. Cardial. 65:521-523; 1990.
32. 10 therapy in patients with congestive heart failure: A long-term multicenter randomized study. Clin. Invest. 71(suppl. 8):S134-S136; 1993.
33. 10 as adjuvant therapy in heart failure. Clin. invest. 71(suppl. 8):S129-S133; 1993.
34. 10 Drug Surveillance Investigators. Mol. Aspects Med. 15: 287-294; 1994.
35. 10 illuminated by meta-analyses of clinical trials. Mol. Aspects Med. 18:S159-S168; 1997.
36. 10 of canine myocardial reperfusion injury after preservation. J. Thorac. Cardiovasc. Surg. 103:945-951; 1992.